Psyence Group Inc.
PSYG
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 59.24% | 233.72% | 1.60% | 36.49% | -2.02% |
| Depreciation & Amortization | -90.36% | -91.38% | -93.02% | 11.46% | -16.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 55.99% | 264.61% | -50.71% | -37.41% | -20.40% |
| Operating Income | -55.99% | -264.61% | 50.71% | 37.41% | 20.40% |
| Income Before Tax | -913.19% | 691.17% | 158.10% | -2,332.08% | 131.84% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -913.19% | 691.17% | 158.10% | -2,332.08% | 131.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -913.19% | 691.17% | 158.10% | -2,332.08% | 131.84% |
| EBIT | -55.99% | -264.61% | 50.71% | 37.41% | 20.40% |
| EBITDA | -59.75% | -283.53% | 50.27% | 37.86% | 20.59% |
| EPS Basic | -889.38% | 658.84% | 152.82% | -1,625.19% | 120.43% |
| Normalized Basic EPS | -469.27% | -257.53% | 96.58% | -1,488.08% | 120.04% |
| EPS Diluted | -889.38% | 658.84% | 152.82% | -1,625.19% | 120.43% |
| Normalized Diluted EPS | -469.27% | -257.53% | 96.58% | -1,488.08% | 120.04% |
| Average Basic Shares Outstanding | 2.90% | 5.76% | 9.99% | 40.99% | 55.97% |
| Average Diluted Shares Outstanding | 2.90% | 5.76% | 9.99% | 40.99% | 55.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |